A critical time for rotavirus vaccines: a review

References

• Centers for Disease Control. Intussusception among recipients of rotavirus vaccine–USA, 1998–1999. Morb. Mortal. Wkly Rep. 48, 577–581 (1999).
   PubMedGoogle Scholar
• Centers for Disease Control. Withdrawal of rotavirus vaccine recommendation. Morb. Mortal. Wkly Rep. 48, 1007 (1999).
   PubMedGoogle Scholar
• Roberts L. Rotavirus vaccines’ second chance. Science 305, 1890–1893 (2004).
   PubMed Web of Science ®Google Scholar
• Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 4, 2207–2222 (1999).
   Google Scholar
• Cunliffe NA, Bresee JS, Hart CA. Rotavirus vaccines: development, current issues and future prospects. J. Infect. 45, 1–9 (2002).
   PubMed Web of Science ®Google Scholar
• Estes MK. Rotaviruses and their replication. In: Fields Virology. (4th Edition). DM Knipe, PM Howley (Eds). Lippincott-Williams & Willkins, Philadelphia, PA, USA, 1747–1785 (2001).
   Google Scholar
• Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 15, 29–56 (2005).
   PubMed Web of Science ®Google Scholar
• McNeal MM, Sestak K, Choi AH et al. Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype. J. Virol. 79, 944–954 (2005).
   PubMedGoogle Scholar
• Koshimura Y, Nakagomi T, Nakagomi O. The relative frequencies of G serotypes of rotaviruses recovered from hospitalized children with diarrhea: a 10-year survey (1987–1996) in Japan with a review of global collection of data. Microbiol. Immunol. 44, 499–510 (2000).
   PubMed Web of Science ®Google Scholar
• Gentsch JR, Laird AR, Bielfelt B et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J. Infect. Dis. 192, S146–S159 (2005).
   PubMed Web of Science ®Google Scholar
• Oka T, Nakagomi T, Nakagomi O. Apparent re-emergence of serotype G9 in 1995 among rotaviruses recovered from Japanese children hospitalized with acute gastroenteritis. Microbiol. Immunol. 44, 957–961 (2000).
   PubMedGoogle Scholar
• Laird AR, Gentsch JR, Nakagomi T, Nakagomi O, Glass RI. Characterization of serotype G9 rotavirus strains isolated in the USA and India 1993–2001. J. Clin. Microbiol. 41, 3100–3111 (2003).
   PubMedGoogle Scholar
• Griffin DD, Kirkwood CD, Parashar UD et al. Surveillance of rotavirus strains in the USA: identification of unusual strains. J. Clin. Microbiol. 38, 2784–2787 (2000).
   PubMedGoogle Scholar
• Hoshino Y, Jones RW, Ross J et al. Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J. Virol. 78, 7795–7802 (2004).
   PubMedGoogle Scholar
• Kapikian AZ, Hoshino Y, Chanock RM. Rotaviruses. In: Fields Virology. (4th Edition). DM Knipe, PM Howley (Eds). Lippincott-Williams & Wilkins, PA, USA, 1787–1833 (2001).
   Google Scholar
• Dormitzer PR. Rotaviruses. In: Principles and Practice of Infectious Diseases. (6th Edition). GL Mandell, JE Bennett, R Dolin (Eds). Elsevier, PA, USA, 1902–1913 (2005).
   Google Scholar
• Ward RL, Clark HF, Offit PA, Glass RI. Live vaccine strategies to prevent rotavirus disease. In: New Generation Vaccines. (3rd Edition). MM Levine, JB Kaper, R Rappuoli, MA Aiu, MF Good (Eds). Marcel Dekker, Inc., Basel, Switzerland, 607–620 (2004).
   Google Scholar
• Ward RL. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol. 16, 17–24 (2003).
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Bresee JS, Gentsch JR, Glass RI, Hart CA. The expanding diversity of rotaviruses. Lancet 359, 640–642 (2002).
   PubMed Web of Science ®Google Scholar
• Iturriza-Gomara M, Anderton E, Kang G et al. Evidence for genetic linkage between the gene segments encoding NSP4 and VP6 proteins in common and reassortant human rotavirus strains. J. Clin. Microbiol. 41, 3566–3573 (2003).
   PubMedGoogle Scholar
• Watanabe M, Nakagomi T, Koshimura Y, Nakagomi O. Direct evidence for genome segment reassortment between concurrently-circulating human rotavirus strains. Arch. Virol. 146, 577–570 (2001).
   Google Scholar
• Nakagomi O, Nakagomi T. Genomic relationships among rotaviruses recovered from various animal species as revealed by RNA–RNA hybridization assays. Res. Vet. Sci. 73, 207–214 (2002).
   PubMed Web of Science ®Google Scholar
• Palombo EA. Genetic analysis of Group A rotaviruses: evidence for interspecies transmission of rotavirus genes. Virus Genes 24, 11–20 (2002).
   PubMed Web of Science ®Google Scholar
• Gouvea V, Santos N. Rotavirus serotype G5: an emerging cause of epidemic childhood diarrhea. Vaccine 17, 1291–1292 (1999).
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Gentsch JR, Kirkwood CD et al. Molecular and serologic characterization of novel serotype G8 human rotavirus strains detected in Blantyre, Malawi. Virology 274, 309–320 (2000).
   PubMed Web of Science ®Google Scholar
• Adah MI, Nagashima S, Wakuda M, Taniguchi K. Close relationship between G8 serotype bovine and human rotaviruses isolated in Nigeria. J. Clin. Microbiol. 41, 3945–3950 (2003).
   PubMedGoogle Scholar
• Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 365, 1147–1152 (2005).
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9, 565–572 (2003).
   PubMed Web of Science ®Google Scholar
• De Zoysa I, Feachem RG. Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull. World Health Organ. 63, 569–583 (1985).
   PubMed Web of Science ®Google Scholar
• Parashar UD, Bresee JS, Glass RI. The global burden of diarrhoeal disease in children. Bull. World Health Organ. 81, 236 (2003).
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. The prospects of immunizing against rotavirus. In: New Vaccine Development: Diseases of Importance in Developing Countries. Volume 2. National Academy Press, Washington DC, USA, D13-1–D13-12 (1986).
   Google Scholar
• Miller MA, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type B, Streptococcus pneumoniae-conjugate and rotavirus vaccines in National immunization schedules. Health Econ. 9, 19–35 (2000).
   PubMed Web of Science ®Google Scholar
• Parashar U. Proceedings of the Sixth International Rotavirus Symposium. Mexico City, Mexico, 7–9 July 2004.
   Google Scholar
• Bresee J, Fang ZY, Wang B et al. First report from the Asian Rotavirus Surveillance Network. Emerg. Infect. Dis. 10, 988–995 (2004).
   PubMed Web of Science ®Google Scholar
• Smith JC, Haddix AC, Teutsch SM, Glass RI. Cost–effectiveness analysis of a rotavirus immunization program for the USA. Pediatrics 96, 609–615 (1995).
   PubMed Web of Science ®Google Scholar
• Ryan MJ, Ramsay M, Brown D, Gay NJ, Farrington CP, Wall PG. Hospital admissions attributable to rotavirus infection in England and Wales. J. Infect. Dis. 174(Suppl. 1), S12–S18 (1996).
   Google Scholar
• Lynch M, O’Halloran F, Whyte D, Fanning S, Cryan B, Glass RI. Rotavirus in Ireland: national estimates of disease burden, 1997 to 1998. Pediatr. Infect. Dis. J. 20, 693–698 (2001).
   PubMed Web of Science ®Google Scholar
• Hiramoto I, Nakagomi T, Nakagomi O. Population-based estimates of the cumulative risk of hospitalization that was potentially associated with rotavirus diarrhea among children living in two cities in Akita Prefecture, Japan. Jpn J. Infect. Dis. 58, 73–77 (2005).
   PubMedGoogle Scholar
• Nakagomi T, Nakagomi O, Takahashi Y, Enoki M, Suzuki T, Kilgore PE. The incidence and burden of rotavirus gastroenteritis in Japan as estimated from a prospective sentinel hospital study. J. Infect. Dis. 192, S106–S110 (2005).
   PubMedGoogle Scholar
• Vesikari T, Rautanen T, Von Bonsdorff CH. Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features. Acta Paediatr.(Suppl.) 88, 24–30 (1999).
   PubMedGoogle Scholar
• Verstraeten T, Wolleswinkel-Van Den Bosch JH. Burden of rotavirus disease in the New European Union. 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases. Valencia, Spain, 18–20 May, 2005.
   Google Scholar
• Hsu VP, Staat MA, Roberts N et al. Use of active surveillance to validate International Classification of Diseases code estimates of rotavirus hospitalizations in children. Pediatrics 115, 78–82 (2005).
   PubMed Web of Science ®Google Scholar
• Riordan FAI, Quigley T. Estimating hospital admissions due to rotavirus gastroenteritis from hospital episode statistics. J. Infect. 49, 13–16 (2004).
   PubMedGoogle Scholar
• Fischer TK, Bresee JS, Glass RI. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 22(Suppl. 1), S49–S54 (2004).
   PubMed Web of Science ®Google Scholar
• Nakajima H, Nakagomi T, Kamisawa T et al. Winter seasonality and rotavirus diarrhoea in adults. Lancet 357, 1950 (2001).
   PubMed Web of Science ®Google Scholar
• Marshall J, Botes J, Gorrie G et al. Rotavirus detection and characterisation in outbreaks of gastroenteritis in aged-care facilities. J. Clin. Virol. 28, 331–340 (2003).
   PubMedGoogle Scholar
• Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N. Engl. J. Med. 309, 72–76 (1983).
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Calva JJ et al. Rotavirus infection in infants as protection against subsequent infections. N. Engl. J. Med. 335, 1022–1028 (1996).
   PubMed Web of Science ®Google Scholar
• Vesikari T. Rotavirus vaccine studies in Europe. Acta Paediatr. Suppl. 426, 9–13 (1999).
   Google Scholar
• Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomized placebo-controlled trial of rhesus–human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 350, 1205–1209 (1997).
   PubMed Web of Science ®Google Scholar
• Rennels MB, Glass RI, Dennehy PH et al. Safety and efficacy of high-dose rhesus human reassortant rotavirus vaccines – Report of the National Multicenter Trial. Pediatrics 97, 7–13 (1996).
   PubMed Web of Science ®Google Scholar
• Perez-Schael I, Guntiñas MJ, Perez M et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N. Engl. J. Med. 337, 1181–1187 (1997).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 102, 1483–1491 (1998).
   PubMedGoogle Scholar
• Bernstein DI, Sack DA, Rothstein E et al. Efficacy of live, attenuated, human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial. Lancet 354, 287–290 (1999).
   PubMed Web of Science ®Google Scholar
• De Vos B, Vesikari T, Linhares AC et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 10(Suppl.), S179–S182 (2004).
   Google Scholar
• Velazquez FR, Abate H, Costa Clemens SA et al. The human monovalent G1P[8] rotavirus vaccine, Rotarix is highly efficacious and provides cross-protection against G1 and non G1 serotypes. 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases. Valencia, Spain, 18–20 May, 2005.
   Google Scholar
• Desselberger U. RotaTeq® (Sanofi Pasteur/Wistar Institute/Children’s Hospital of Philadelphia). Curr. Opin. Invest. Drugs 6, 199–208 (2005).
   PubMedGoogle Scholar
• Vesikari T, Matson D, Dennehy P et al. Protection against rotavirus gastroenteritis of multiple serotypes by a pentavalent (human–bovine) reassortant rotavirus vaccine (PRV). 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases. Valencia, Spain, 18–20 May 2005.
   Google Scholar
• Kombo LA, Gerber MA, Pickering LA, Atreya CD, Breiman RF. Intussusception, infection, and immunization: summary of a workshop on rotavirus. Pediatrics 108, E37 (2001).
   Google Scholar
• Nakagomi T. Rotavirus infection and intussusception: a view from retrospect. Microbiol. Immunol. 44, 619–628 (2000).
   PubMed Web of Science ®Google Scholar
• Chang EJ, Zangwill KM, Lee H, Ward JI. Lack of association between rotavirus infection and intussusception: implication for use of attenuated rotavirus vaccines. Pediatr. Infect. Dis. J. 21, 97–102 (2002).
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Luna G, Cedillo R, Torres J, Munoz O. Natural rotavirus infection is not associated to intussusception in Mexican children. Pediatr. Infect. Dis. J. 10(Suppl.), S173–S178 (2004).
   Google Scholar
• Rennels MB, Parashar UD, Holman RC, Le CT, Chang HG, Glass RI. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr. Infect. Dis. J. 17, 924–925 (1998).
   PubMed Web of Science ®Google Scholar
• Murphy TV, Gargiullo PM, Massoudi MS et al. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 344, 564–572 (2001).
   PubMed Web of Science ®Google Scholar
• Kramarz P, France EK, Destefano F et al. Population-based study of rotavirus vaccination and intussusception. Pediatr. Infect. Dis. J. 20, 410–416 (2001).
   PubMed Web of Science ®Google Scholar
• Simonsen L, Morens DM, Elixhauser A, Gerber M, Van Raden M, Blackwelder WC. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 358, 1224–1229 (2001).
   PubMed Web of Science ®Google Scholar
• Chang HGH, Smith PF, Ackelsberg J, Morse DL, Glass RI. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York State. Pediatrics 108, 54–60 (2001).
   PubMedGoogle Scholar
• Peter G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 110, e67 (2002).
   PubMed Web of Science ®Google Scholar
• Murphy BR, Morens DM, Simonsen L, Chanock RM, La Montagne JR, Kapikian AZ. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J. Infect. Dis. 187, 1301–1308 (2003).
   PubMed Web of Science ®Google Scholar
• Glass RI, Bresee JS, Parashar UD, Jiang B, Gentsch JR. The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet 363, 1547–1550 (2004).
   PubMed Web of Science ®Google Scholar
• Bines JE. Rotavirus vaccines and intussusception risk. Curr. Opin. Gastroenterol. 21, 20–25 (2005).
   PubMed Web of Science ®Google Scholar
• Vesikari T, O’Ryan M, Abate H et al. Overcoming the safety hurdle: the rotavirus vaccine RIX4414 is not associated with intussusception. 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases. Valencia, Spain, 18–20 May, 2005.
   Google Scholar
• Vesikari T, Matson DO, Van Damme P et al. Incidence of intussusception with the pentavalent (human-bovine) reassortant rotavirus vaccine (PRV) is similar to placebo. 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases. Valencia, Spain, 18–20 May 2005.
   Google Scholar
• Robinson CG, Hernanz-Schulman M, Zhu Y, Griffin MR, Gruber W, Edwards KM. Evaluation of anatomic changes in young children with natural rotavirus infection: is intussusception biologically plausible? J. Infect. Dis. 189, 1382–1387 (2004).
   PubMed Web of Science ®Google Scholar
• Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J. Virol. 78, 10213–10220 (2004).
   PubMed Web of Science ®Google Scholar
• Blutt SE, Kirkwood CD, Parreno V et al. Rotavirus antigenaemia and viraemia: a common event? Lancet 362, 1445–1449 (2003).
   PubMed Web of Science ®Google Scholar
• Chiappini E, Azzari C, Moriondo M, Galli L, de Martino M. Viraemia is a common finding in immunocompetent children with rotavirus infection. J. Med. Virol. 76, 265–267 (2005).
   PubMedGoogle Scholar
• Nakagomi T, Nakagomi O. Rotavirus antigenemia in children with encephalopathy accompanied by rotavirus gastroenteritis. Arch. Virol. 150, 1927–1931 (2005).
   PubMed Web of Science ®Google Scholar
• Saulsbury FT, Winkelstein JA, Yolken RH. Chronic rotavirus infection in immunodeficiency. J. Pediatr. 97, 61–65 (1980).
   PubMed Web of Science ®Google Scholar
• Wecker J. Costs of a rotavirus vaccine. Science 307, 517–519 (2005).
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Saari TN, McMahon SR et al. A survey of pediatricians on the reintroduction of a rotavirus vaccine. Pediatrics 112, e6–e10 (2003).
   Google Scholar
• Hoshino Y, Jones RW, Ross J, Kapikian AZ. Construction and characterization of rhesus monkey rotavirus (MMU18006) – or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines. Vaccine 21, 3003–3010 (2003).
   PubMedGoogle Scholar
• Hoshino Y, Jones RW, Ross J, Kapikian AZ. Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: construction and characterization. Vaccine 23, 3791–3799 (2005).
   PubMedGoogle Scholar
• Nakagomi T. Intussusception and oral rotavirus vaccine. N. Engl. J. Med. 344, 1866 (2001).
   PubMedGoogle Scholar
• Braine T. Rotavirus vaccine introduction in Mexico sets precedent. Bull. World Health Organ. 83, 167 (2005).
   PubMedGoogle Scholar
• Hopes and fears for rotavirus vaccines. Lancet 365, 190 (2005).
   PubMedGoogle Scholar
• Ferguson SM. Department of Health and Human Services. National Institutes of Health. Prospective grant of partially-exclusive licenses: human-bovine reassortant rotavirus vaccine. Federal Register 69, 57335–57336 (2004).
   Google Scholar